These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9239513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M.
    Int J Cancer; 1997 Jan 06; 70(1):120-7. PubMed ID: 8985100
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
    Keyszer G, Redlich A, Häupl T, Zacher J, Sparmann M, Engethüm U, Gay S, Burmester GR.
    Arthritis Rheum; 1998 Aug 06; 41(8):1378-87. PubMed ID: 9704635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue.
    Arkona C, Wiederanders B.
    Biol Chem; 1996 Nov 06; 377(11):695-702. PubMed ID: 8960370
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
    Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP.
    Cancer Lett; 1995 Sep 25; 96(2):267-75. PubMed ID: 7585467
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
    Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ.
    Br J Cancer; 1998 Dec 25; 78(11):1495-502. PubMed ID: 9836483
    [Abstract] [Full Text] [Related]

  • 16. Correspondence re: N-B. Liabakk et al., matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56: 190-196, 1966.
    Zucker S.
    Cancer Res; 1996 Aug 01; 56(15):3610. PubMed ID: 8758934
    [No Abstract] [Full Text] [Related]

  • 17. Cathepsin K is the principal protease in giant cell tumor of bone.
    Lindeman JH, Hanemaaijer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D, Verheijen JH, Hogendoorn PC.
    Am J Pathol; 2004 Aug 01; 165(2):593-600. PubMed ID: 15277232
    [Abstract] [Full Text] [Related]

  • 18. Cysteine protease activities and tumor development in human colorectal carcinoma.
    Sheahan K, Shuja S, Murnane MJ.
    Cancer Res; 1989 Jul 15; 49(14):3809-14. PubMed ID: 2544258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.